AlphAIAlphAI — Financial news for AI agents
247wallst.comOCT 262 min read$BRO

Brown & Brown Q3 2026: Accession Costs Squeeze Margins as Organic Growth Slows

Brown & Brown missed Q3 2026 earnings expectations, reporting adjusted diluted EPS of $1.07. Organic revenue grew 1.2%, with acquisition-driven gains. Adjusted EBITDAC margin compressed 200 basis points to 34.6% due to integration costs. CEO J. Powell Brown noted challenges from a softening insurance rate environment. The company repurchased $750 million of treasury stock in 2026.

Original reporting
247wallst.com
Published Oct 26, 2026, 9:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 26, 2026, 10:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Brown & Brown Q3 2026: Accession Costs Squeeze Margins as Organic Growth Slows — source image
Source · 247wallst.com
Decision brief

The 30-second read

$BROBearishMed
01

Why it matters

The earnings miss may trigger short-term price declines, but the large share repurchase could provide support.

02

Market read

Earnings miss for a mid-cap insurer, relevant for insurance sector investors.

03

What to watch

Potential upside from the $750M treasury repurchase indicating confidence in long-term outlook.

Relevance 7/10Novelty 7/10Timing: after-hours

Background

Brown & Brown's Q3 2026 earnings release highlights slowed organic growth and margin pressure from the Accession acquisition.

Company-level read

Ticker impact

$BROBearishHigh confidence
Context

Brown & Brown reported Q3 2026 earnings miss with adjusted EPS $1.07 and margin compression, indicating near-term pressure.

Expected impact

likely pressure as the market prices in lower earnings and margin compression

Evidence & confidence

The company missed both top and bottom line expectations and highlighted integration costs, which typically trigger a sell-off.

Market effects

Sector

Insurance sector may face scrutiny over integration costs and rate environment.

Regional

U.S. insurers could see modest sell pressure.

Global

Limited to U.S. insurance market participants.

Counterpoint

What could challenge this read

If integration synergies materialize faster than expected, the stock could rebound.

Key entities

  • company
    Brown & Brown

    U.S. insurance brokerage firm reporting Q3 2026 results.

Read at source← All news

StoryBrown & Brown reports Q3 growth as organic expansion and margins weaken

Also covered by

4 outlets

Related articles

OCT 27
$BROMed

Brown & Brown Inc (BRO) (Q3 2026) Earnings Call Highlights: Revenue Up 7.4%

Brown & Brown Inc (BRO) reported Q3 2026 revenue up 7.4% to $1.07B, but adjusted EBITDAC margin fell 200 bps to 34.6%. Specialty Distribution organic revenue declined 0.8%, missing expectations due to competition and pricing pressures. The company anticipates further declines in Q4 and faces ongoing litigation impacts. Integration costs for Accession have increased to $250-300M.

finance.yahoo.com3 min
OCT 27
$BROMed

What Brown & Brown (BRO) Said on Its Q3 Earnings Call

Brown & Brown (BRO) reported Q3 earnings, noting market shifts in California and Texas, and pricing pressures in commercial earthquake business. The company expects 2027 growth of 2%-4% for retail and 1%-3% for specialty distribution. Accession acquisition raised synergy targets to $50M for 2026 and $175M by 2028. AI initiatives are expanding across the company, with tools like Claude and COMPASS being deployed. The board increased the dividend by 9%.

finance.yahoo.com3 min
OCT 27
$BROHighAI 8/10

Brown & Brown (BRO) Q3 2026 Earnings Call Transcript

Brown & Brown (BRO) reported Q3 2026 revenues of $1.7B, up 7.4% YoY. Organic revenue grew 1.2%, while adjusted EBITDAC margin fell 200 bps to 34.6%. Adjusted EPS rose 2% to $1.07. The company raised its dividend by 9%, marking 33 consecutive years of increases. Retail segment outperformed expectations, while specialty distribution faced headwinds. The company repurchased $750M in shares YTD, including $250M in Q3.

finance.yahoo.com2 min
OCT 27
$BROMed

Truist cuts Brown & Brown stock price target to $85 on lower estimates

Truist Securities reduced its price target for Brown & Brown (NYSE:BRO) to $85 from $90, citing lower 2026 and 2027 EPS estimates. The firm maintained a Buy rating, basing the target on a 14x multiple of its 2027 EBITDA estimate. BRO's Q3 earnings missed expectations, with revenue at $1.72B and EPS at $1.07, though both showed year-over-year growth. The company's organic growth slowed, and its adjusted EBITDAC margin declined by 200 basis points.

investing.com2 min
OCT 27
$BROMed

Why Brown & Brown (BRO) stock is trading lower today

Brown & Brown (BRO) shares fell 4.9% after reporting Q3 2026 revenue of $1.73B, up 7.4% YoY, but with slowing organic growth and margin compression. CEO Powell Brown noted declines in excess-and-surplus property rates and expected further decreases in 2027. The stock is down 13.4% YTD, trading at $67.25, 23.4% below its 52-week high.

financialcontent.com2 min